VA to review possible service connection between PFAS exposure and kidney cancer
WASHINGTON — Today, the U.S. Department of Veterans Affairs announced that it will conduct a scientific assessment to determine if there is a relationship between per- and polyfluoroalkyl substances (PFAS) exposure during military service and kidney cancer among Veterans.
This scientific assessment — a process codified under the PACT Act — will help VA determine if kidney cancer should be considered a presumptive service-connected condition for Veterans exposed to PFAS. When a condition is considered presumptive, eligible Veterans do not need to prove that their service caused their disease in order to receive benefits for it; instead, if they served in certain locations during certain time periods, VA automatically assumes (or “presumes”) that exposure during military service caused the disease and provides benefits accordingly.
This review is a part of the Biden-Harris Administration’s efforts to expand benefits and services for toxic-exposed Veterans and their families, and helps advance the President’s Unity Agenda and Biden Cancer Moonshot goals to understand and address environmental and toxic exposures and end cancer as we know it. As a part of these efforts, VA expedited health care and benefits eligibility under the PACT Act by several years — including extending presumptions for head cancer, neck cancer, gastrointestinal cancer, reproductive cancer, lymphoma, pancreatic cancer, kidney cancer, melanoma, hypertension for Vietnam Veterans, and much more. Since the PACT Act was signed into law, VA has extended presumptions for more than 300 new conditions, including most recently for male breast cancer, urethral cancer, and cancer of the paraurethral glands.
“At VA, we want to understand the health conditions that Veterans are living with so we can provide them with all of the benefits they deserve — and that’s what this review process is all about,” said VA Secretary Denis McDonough. “As a result of this scientific review, we may be able to make kidney cancer a presumptive condition for Veterans exposed to PFAS, thus lowering the burden of proof on these Veterans. But make no mistake: Veterans should not wait for the outcome of this review to apply for the benefits and care they deserve. If you’re a Veteran and believe your military service has negatively impacted your health, we encourage you to apply for VA care and benefits today.”
PFAS are a class of over 12,000 chemicals and have been used in the military since the early 1970s. VA’s assessment methodology follows guidance from the National Academies of Sciences, Engineering, and Medicine and other key stakeholders, and will consider available peer-reviewed scientific literature, Veteran claims data, and other relevant data. Regardless of whether a condition is an established presumptive condition, VA will consider claims on a case-by-case basis and can grant disability compensation benefits if sufficient evidence of service connection is found — and VA is always working to get to yes.
VA prioritizes claims processing for Veterans with cancer and offers comprehensive cancer care services to Veterans across the nation — from screening through treatment. Since President Biden signed the PACT Act into law, VA has delivered disability compensation benefits to more than one million Veterans and their survivors, amounting to more than $7 billion in earned PACT Act benefits. During the same period, nearly 740,000 Veterans have enrolled in VA care and more than 5.6 million Veterans have been screened for toxic exposures.
VA is soliciting public comment on the proposed scientific assessment between PFAS exposure and kidney cancer via the Federal Register. The public will have a 30-day period to provide comments. VA will also host a listening session Nov. 19, 2024, to allow individuals to share research and input. Individuals interested may register to participate. The public may also comment via either forum on other conditions that would benefit from review for potential service-connection.
###
